PapersFlow Research Brief
Organ and Tissue Transplantation Research
Research Guide
What is Organ and Tissue Transplantation Research?
Organ and Tissue Transplantation Research is the study of advancements in transplantation procedures and outcomes, including uterus, face, hand, and composite tissue transplantation, along with clinical outcomes, rejection patterns, immunosuppression strategies, psychological aspects, and ethical considerations.
The field encompasses 26,980 works on transplantation topics. Key areas include lung rejection nomenclature, heart-lung transplantation survival rates averaging 50%, and placental blood as a source for hematopoietic stem cells. Research also covers historical techniques like rat heart transplantation and early human liver homotransplantation.
Topic Hierarchy
Research Sub-Topics
Acute and Chronic Allograft Rejection Mechanisms
This sub-topic examines the immunological pathways and histopathological changes leading to acute and chronic rejection in solid organ transplants. Researchers study T-cell mediated rejection, antibody-mediated rejection, and diagnostic criteria like the Banff classification.
Immunosuppression Regimen Optimization
This area focuses on balancing efficacy and toxicity of immunosuppressive drugs like calcineurin inhibitors, mTOR inhibitors, and biologics in transplant recipients. Studies compare protocols such as steroid withdrawal and minimization strategies.
Composite Tissue Allotransplantation Outcomes
Research covers vascularized composite allografts including face, hand, and uterus transplants, analyzing surgical techniques, functional recovery, and rejection patterns. It includes multicenter registries and long-term follow-up data.
Transplant Donor Selection Criteria
This sub-topic investigates extended criteria donors, marginal donors, and machine perfusion for organ viability assessment. Researchers develop scoring systems and biomarkers for predicting graft function.
Psychosocial Outcomes in Transplant Recipients
Studies explore mental health, adherence to therapy, quality of life, and return-to-work post-transplant. It addresses pre-transplant psychological evaluations and interventions for body image in visible transplants.
Why It Matters
Organ and Tissue Transplantation Research directly improves patient survival and graft function across procedures. For example, Stewart et al. (2007) in "Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung Rejection" standardized lung rejection diagnosis, aiding consistent clinical assessment in over 2,400 cited cases. Griffith et al. (2016) in "Heart-Lung Transplantation" reported average 50% survival rates, identifying donor criteria and immunosuppression gaps that guide protocols for cardiopulmonary patients. Rubinstein et al. (1998) demonstrated outcomes in 562 recipients of placental-blood transplants, establishing it as a viable unrelated donor source for bone marrow reconstitution and expanding hematopoietic stem cell availability. These contributions enhance rejection management, as in Medawar (1948) on skin graft immunity, and support therapies like mesenchymal stem cells suppressing T lymphocyte function to prevent graft-versus-host disease, as shown by Selmani et al. (2007).
Reading Guide
Where to Start
"Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung Rejection" by Stewart et al. (2007), as it provides a foundational standardization of rejection diagnosis central to clinical transplantation practice and has the highest citations at 2413.
Key Papers Explained
Stewart et al. (2007) "Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung Rejection" establishes diagnostic standards that underpin later works like Weill et al. (2014) "A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation," which builds on rejection knowledge for candidate selection. Griffith et al. (2016) "Heart-Lung Transplantation" extends this to cardiopulmonary outcomes, citing 50% survival and linking to historical techniques in Ono and Lindsey (1969) "Improved technique of heart transplantation in rats." Early immunity insights from Medawar (1948) "Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye" inform modern immunomodulation in Selmani et al. (2007) "Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells." Starzl et al. (1963) "HOMOTRANSPLANTATION OF THE LIVER IN HUMANS." provides pioneering clinical data connecting to current organ-specific strategies.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus shifts to composite tissue transplantation like face and hand, with ongoing needs for better immunosuppression and rejection management based on lung and heart-lung standards. No recent preprints or news available, so current frontiers emphasize refining HLA-G mechanisms from Selmani et al. (2007) and candidate selection from Weill et al. (2014) for uterus and ethical considerations.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Revision of the 1996 Working Formulation for the Standardizati... | 2007 | The Journal of Heart a... | 2.4K | ✕ |
| 2 | Heart-Lung Transplantation | 2016 | — | 2.2K | ✓ |
| 3 | Implantation and the placenta: key pieces of the development p... | 1994 | Science | 1.4K | ✕ |
| 4 | Outcomes among 562 Recipients of Placental-Blood Transplants f... | 1998 | New England Journal of... | 1.3K | ✕ |
| 5 | Improved technique of heart transplantation in rats | 1969 | Journal of Thoracic an... | 1.3K | ✕ |
| 6 | A consensus document for the selection of lung transplant cand... | 2014 | The Journal of Heart a... | 1.3K | ✕ |
| 7 | Roadmap to embryo implantation: clues from mouse models | 2006 | Nature Reviews Genetics | 1.3K | ✕ |
| 8 | HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. | 1963 | PubMed | 1.2K | ✕ |
| 9 | Immunity to homologous grafted skin; the fate of skin homograf... | 1948 | PubMed | 1.1K | ✓ |
| 10 | Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem... | 2007 | Stem Cells | 1.1K | ✓ |
Frequently Asked Questions
What standardized nomenclature exists for lung rejection diagnosis?
Stewart et al. (2007) revised the 1996 Working Formulation in "Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung Rejection" to standardize lung rejection terminology. This update facilitates consistent pathological diagnosis in lung transplant patients. It has been cited 2413 times, reflecting its widespread clinical use.
How do survival rates compare in heart-lung transplantation?
Griffith et al. (2016) in "Heart-Lung Transplantation" report average 50% survival rates for cardiopulmonary transplantation, lower than cardiac transplantation alone. Differences arise from donor criteria, surgical techniques, and immunosuppression challenges. Advances in these areas aim to improve outcomes.
What is the role of placental blood in transplantation?
Rubinstein et al. (1998) in "Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors" show placental blood serves as a source of allogeneic hematopoietic stem cells for bone marrow reconstitution. Among 562 recipients, it supported successful engraftment from unrelated donors. This expands transplant options beyond matched marrow.
What technique improved heart transplantation in animal models?
Ono and Lindsey (1969) in "Improved technique of heart transplantation in rats" developed a refined surgical method for rat heart transplants. This technique enhanced experimental reproducibility and success rates. It remains a foundational model for studying rejection and immunosuppression.
How do mesenchymal stem cells modulate immunity in transplantation?
Selmani et al. (2007) in "Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells" demonstrate that HLA-G5 secretion by MSCs suppresses T lymphocytes and NK cells while inducing regulatory T cells. This immunomodulation has potential to prevent graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. MSCs from adult bone marrow provide therapeutic immunomodulatory effects.
What were early outcomes in human liver homotransplantation?
Starzl et al. (1963) in "HOMOTRANSPLANTATION OF THE LIVER IN HUMANS." reported on three patients, with the first dying intraoperatively from hemorrhage and the second and third surviving 22 and 7.5 days. These cases identified key challenges like bleeding and short-term survival. They laid groundwork for clinical liver transplantation protocols.
Open Research Questions
- ? What factors most limit long-term survival in heart-lung transplantation beyond the reported 50% average?
- ? How can HLA-G5 secretion mechanisms in mesenchymal stem cells be optimized to better prevent graft-versus-host disease?
- ? What refinements to lung transplant candidate selection criteria from 2014 consensus improve outcomes in diverse patient populations?
- ? Why do skin homografts transplanted to brain or eye sites evade immunity compared to subcutaneous sites?
- ? What surgical and immunological barriers persist from early liver homotransplantation experiences?
Recent Trends
The field holds steady at 26,980 works with no 5-year growth rate available, indicating sustained research volume without specified acceleration.
High-citation classics like Stewart et al. at 2413 citations continue dominating, while Griffith et al. (2016) at 2160 citations reflect persistent focus on heart-lung challenges.
2007No recent preprints or news in the last 12 months reported.
Research Organ and Tissue Transplantation Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Organ and Tissue Transplantation Research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers